Cargando…

LIPI及iSEND免疫评分在晚期非小细胞肺癌免疫治疗中的预测价值分析

BACKGROUND AND OBJECTIVE: This study retrospectively analyzed the application value of lung cancer immunotherapy prognostic index (LIPI) and iSEND immune scoring system in advanced non-small cell lung cancer (NSCLC) patients treated with immunotherapy in China, in order to find guidance for clinical...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720679/
https://www.ncbi.nlm.nih.gov/pubmed/36419394
http://dx.doi.org/10.3779/j.issn.1009-3419.2022.102.47